Aperam

Downward revision after the Q125 results.

08/05/25 -"Our target price goes down in line with our earnings reduction, in particular due to comparables. This is a touch less the case for our DCF, since our working capital assumptions were probably a ..."

PDF page sample
Pages
63
Language
English
Published on
08/05/25
Download
You may also be interested by these reports :
15/05/25
The Q125 results aligned with the February outlook, which anticipates a similar Q2 and improved volumes and prices in H2. Considering the subdued oil ...
15/05/25
Sales in-line with consensus. Weak operating profit. Outlook confirmed. Focus on costs and portfolio management
12/05/25
We have cut our forecasts for the current year, as we did for peers Aperam (France) and Acerinox (Spain) and, to a lesser extent, for FY26, following ...
12/05/25
Following the release of the Q125 results, we have cut our forecasts for the current year, as we did for peers Aperam (Luwemburg/France) and ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO